Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Cohen

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Current Oncology (Toronto, Ont.)|December 23, 2021
Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in QuebecJason S Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Journal of Emergency Nursing|March 10, 2010
Pharmacist improves timely administration of medications to boarded patients in the emergency departmentSamantha P Jellinek, Victor Cohen, Lydia B Fancher, et al.
Journal of Integrative Medicine|October 8, 2018
The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility studyGoulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)Jason S Agulnik, Andreas I Papadakis, Carmela Pepe, et al.
Journal of Psychopharmacology (Oxford, England)|September 1, 2021
Three regulatory compliant test systems show no signs of MDMA-related genotoxicityIsaac Victor Cohen, Laken Barber, Tyson Paul Dubnicka, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian PerspectiveJason Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Cancer|June 16, 2010
Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitorsVictor Cohen, Jason S Agulnik, Celina Ang, et al.
Plos One|April 8, 2015
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trialL John Hoffer, Line Robitaille, Robert Zakarian, et al.
Cancer|November 11, 2006
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancerVictor Cohen, Jason S Agulnik, Jonathan Jarry, et al.
The Annals of Pharmacotherapy|November 29, 2013
Feasibility of a pharmacy-based influenza immunization program in an academic emergency departmentVictor Cohen, Samantha P Jellinek-Cohen, Antonios Likourezos, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|December 23, 2021
Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in QuebecJason S Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Journal of Emergency Nursing|March 10, 2010
Pharmacist improves timely administration of medications to boarded patients in the emergency departmentSamantha P Jellinek, Victor Cohen, Lydia B Fancher, et al.
Journal of Integrative Medicine|October 8, 2018
The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility studyGoulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)Jason S Agulnik, Andreas I Papadakis, Carmela Pepe, et al.
Journal of Psychopharmacology (Oxford, England)|September 1, 2021
Three regulatory compliant test systems show no signs of MDMA-related genotoxicityIsaac Victor Cohen, Laken Barber, Tyson Paul Dubnicka, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian PerspectiveJason Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Cancer|June 16, 2010
Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitorsVictor Cohen, Jason S Agulnik, Celina Ang, et al.
Plos One|April 8, 2015
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trialL John Hoffer, Line Robitaille, Robert Zakarian, et al.
Cancer|November 11, 2006
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancerVictor Cohen, Jason S Agulnik, Jonathan Jarry, et al.
The Annals of Pharmacotherapy|November 29, 2013
Feasibility of a pharmacy-based influenza immunization program in an academic emergency departmentVictor Cohen, Samantha P Jellinek-Cohen, Antonios Likourezos, et al.
Pageof 7